WHITE PAPER – MAY 11, 2020

Best Practices in Over-Time Virtual
Patient Engagement

The pharmaceutical industry is energizing its approach to patient engagement, adopting a patient-centric philosophy that prioritizes involving patients in a meaningful way throughout the drug development lifecycle. Both patients and pharmaceutical teams can benefit from over-time, asynchronous communication. We’ve compiled some of our best practices around these types of meetings to help medical affairs, clinical/R&D, and commercial teams get high-quality insights in a virtual engagement setting.

Provide your information to download the resource.



Ready for better engagement?

Request a demo